To: | Kite Pharma, Inc. (trademarks@gilead.com) |
Subject: | U.S. Trademark Application Serial No. 88560289 - BECARZA - N/A |
Sent: | September 05, 2019 11:41:21 AM |
Sent As: | ecom116@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88560289
Mark: BECARZA
|
|
Correspondence Address: |
|
Applicant: Kite Pharma, Inc.
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 05, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by GRETCHEN R. STROUD on September 3, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods are not permitted. 37 C.F.R. §2.71(a).
I. AMENDMENT TO THE IDENTIFICATION OF GOODS
The identification of goods is amended to read as follows:
“Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including for T-Cell immunotherapy” in International Class 5.
See TMEP §§1402.01, 1402.01(e).
II. TRANSLATION STATEMENT
The following statement is added to the record:
The wording “BECARZA” has no meaning in a foreign language.
See 37 C.F.R. §2.61(b); TMEP §809.03.
/Zhaleh Delaney/
Trademark Attorney
Trademark Law Office 116
(571) 272-9153
Zhaleh.Delaney@uspto.gov